Author:
Alijanzadeh Dorsa,Ghazizadeh Yalda,Akbarzadeh Diba,Ghaffari Jolfayi Amir,Irilouzadian Rana,Rezaei Nima
Publisher
Springer International Publishing
Reference84 articles.
1. Aghaei H, Kheirkhah A, Alizadeh AM, Es’ haghi A, Aliakbar-Navahi R, Keikha Z, Chaibakhsh S (2023) Local ocular safety of the subconjunctival injection of cetuximab in rabbits. BMC Ophthalmol 23:155
2. Ahmed M, Cheung N-KV (2014) Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy. FEBS Lett 588:288–297
3. Andersch L, Radke J, Klaus A, Schwiebert S, Winkler A, Schumann E, Grunewald L, Zirngibl F, Flemmig C, Jensen MC, Rossig C, Joussen A, Henssen A, Eggert A, Schulte JH, Künkele A (2019) CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing. BMC Cancer 19:895
4. Andreasen S, Heegaard S, Grauslund M, Homøe P (2016) The interleukin-6/Janus kinase/STAT3 pathway in pleomorphic adenoma and carcinoma ex pleomorphic adenoma of the lacrimal gland. Acta Ophthalmol 94:798–804
5. Andreasen S, Esmaeli B, von Holstein SL, Mikkelsen LH, Rasmussen PK, Heegaard S (2017) An update on tumors of the lacrimal gland. Asia Pac J Ophthalmol 6:159–172